Corcept Therapeutics | CORT - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Alaunos Therapeutics USD -7.84M 633K 2023-12
ANI Pharmaceuticals USD 40.22M 8.74M 2026-03
Ardelyx USD -37.6M 37.2M 2026-03
Aurora Cannabis CAD 11.41M 12.99M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Canopy Growth CAD -157.96M 95.71M 2026-03
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
J&J USD 8.66B 839M 2026-06
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Merck USD -3.53B 6.95B 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Novartis USD 4.27B 430M 2026-06
Novartis USD 3.84B 1.33B 2026-03
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 5M 4.43M 2026-03
Pfizer USD -653M 5.84B 2026-06
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06
TG Therapeutics USD 10.23M 10.13M 2026-06